A high fat-diet can influence IMCL and IHL in rodents and in humans, the time-course of peripheral lipid accumulation in liver and skeletal muscle while switching from a low-fat to a high-fat diet is unknown.
ID
Bron
Verkorte titel
Aandoening
Type 2 diabetes (T2DM), Insulin resistance, Non-Alcoholic Fatty Liver Disease (NAFLD)
Type 2 diabetes, insuline resisstentie en leververvetting
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Main study parameter is the difference in lipid accumulation and insulin sensitivity after a switch from a low-fat diet to a high-fat diet compared to the control group, which stays on a low-fat diet.
Achtergrond van het onderzoek
N/A
Doel van het onderzoek
A high fat-diet can influence IMCL and IHL in rodents and in humans, the time-course of peripheral lipid accumulation in liver and skeletal muscle while switching from a low-fat to a high-fat diet is unknown.
Onderzoeksopzet
T=1, T=21 and T=42 (days).
And additional liver lipid accumulation measurement in HF-group on t=28.
Onderzoeksproduct en/of interventie
Both groups, the control group and the experimental group, will start with 3 weeks on a low-fat diet which will deliver 15 Energy% of energy as protein, 65 En% as CHO and 20 En% as fat. After these 3weeks the experimental group will switch to a high-fat diet (15 En% protein, 30 En% CHO and 55% En% fat). wheras the control group stays on the low-fat diet.
Publiek
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Wetenschappelijk
Department of Human Biology
Maastricht University Medical Center
Patrick Schrauwen
Department of Human Biology
Maastricht University Medical Center
Maastricht 6200 MD
The Netherlands
+31(0)43-388 15 02
p.schrauwen@hb.unimaas.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Male sex;
2. Age 40-65 years;
3. BMI 25-35 kg/m2;
4. Sedentary;
5. Stable dietary habits;
6. Healthy.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Current use of medication that is known to interfere with the results of the study;
2. Consuming more than 20 g of alcohol per day (± 2 units);
3. Serum-γ-glutamyltranspeptidase level > 70 IU/L;
4. A history of cardiovascular disease like congestive heart failure or acute myocardial infarction;
5. Plasma triacylglycerol > 4.5 mmol/L;
6. Familial hypercholesterolemia;
7. A history of liver disease;
8. Unstable body weight (weight gain or loss > 3 kg in the past three months);
9. Abuse of drugs;
10. Participation in another biomedical study within 1 month prior to the screening visit;
11. Impossible or difficult venipuncture during screening;
12. A fasting glucose above 7.0 mmol/L (13);
13. A contraindication to MRI scanning. These contraindications include patients with the following devices:
a. Central nervous system aneurysm clips;
b. Implanted neural stimulator;
c. Implanted cardiac pacemaker or defibrillator;
d. Cochlear implant;
e. Ocular foreign body (e.g. metal shavings);
f. Insulin pump;
g. Metal shrapnel or bullet;
h. Or metal containing corpora aliena in the eye of brains.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL2019 |
NTR-old | NTR2136 |
Ander register | MEC : 07-3-028 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |